vs
Protalix BioTherapeutics, Inc.（PLX）与优客工场（UK）财务数据对比。点击上方公司名可切换其他公司
优客工场的季度营收约是Protalix BioTherapeutics, Inc.的1.8倍（$16.4M vs $9.1M），优客工场净利率更高（-42.2% vs -60.3%，领先18.2%），Protalix BioTherapeutics, Inc.同比增速更快（-49.9% vs -56.1%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-892.0K）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
优客工场，原称UrWork，是总部位于北京的共享办公空间运营商，由毛大庆在2015年创立。目前是全球规模仅次于WeWork的第二大共享办公服务商，在全球三十余个城市布局有办公空间，覆盖上海、新加坡、中国香港、纽约等城市，2018年8月估值达18亿美元，是中国共享办公领域首个本土独角兽企业。
PLX vs UK — 直观对比
营收规模更大
UK
是对方的1.8倍
$9.1M
营收增速更快
PLX
高出6.1%
-56.1%
净利率更高
UK
高出18.2%
-60.3%
自由现金流更多
PLX
多$2.5M
$-892.0K
损益表 — Q4 FY2025 vs Q2 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $16.4M |
| 净利润 | $-5.5M | $-6.9M |
| 毛利率 | 49.4% | — |
| 营业利润率 | -51.1% | -23.6% |
| 净利率 | -60.3% | -42.2% |
| 营收同比 | -49.9% | -56.1% |
| 净利润同比 | -184.8% | -30.2% |
| 每股收益（稀释后） | $-0.06 | $-8.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXUK
| Q4 25 | $9.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $15.7M | — | ||
| Q1 25 | $10.1M | — | ||
| Q4 24 | $18.2M | — | ||
| Q3 24 | $18.0M | — | ||
| Q2 24 | $13.5M | $16.4M | ||
| Q4 23 | $10.5M | — |
净利润PLXUK
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $164.0K | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $-2.2M | $-6.9M | ||
| Q4 23 | $-6.0M | — |
毛利率PLXUK
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 62.5% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 78.7% | — | ||
| Q3 24 | 53.4% | — | ||
| Q2 24 | 29.8% | — | ||
| Q4 23 | 15.5% | — |
营业利润率PLXUK
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | -41.0% | — | ||
| Q4 24 | 39.6% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | -18.0% | -23.6% | ||
| Q4 23 | -53.5% | — |
净利率PLXUK
| Q4 25 | -60.3% | — | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -35.8% | — | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | -16.4% | -42.2% | ||
| Q4 23 | -57.6% | — |
每股收益（稀释后）PLXUK
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.03 | — | ||
| Q2 24 | $-0.03 | $-8.55 | ||
| Q4 23 | $-0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $4.7M |
| 总资产 | $82.3M | $68.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXUK
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $17.9M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.4M | — | ||
| Q2 24 | $23.4M | $10.7M | ||
| Q4 23 | $23.6M | — |
股东权益PLXUK
| Q4 25 | $48.2M | — | ||
| Q3 25 | $52.9M | — | ||
| Q2 25 | $49.9M | — | ||
| Q1 25 | $45.2M | — | ||
| Q4 24 | $43.2M | — | ||
| Q3 24 | $32.4M | — | ||
| Q2 24 | $28.6M | $4.7M | ||
| Q4 23 | $33.6M | — |
总资产PLXUK
| Q4 25 | $82.3M | — | ||
| Q3 25 | $82.3M | — | ||
| Q2 25 | $78.5M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $73.4M | — | ||
| Q3 24 | $61.6M | — | ||
| Q2 24 | $91.5M | $68.0M | ||
| Q4 23 | $84.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-677.0K |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-892.0K |
| 自由现金流率自由现金流/营收 | 17.8% | -5.5% |
| 资本支出强度资本支出/营收 | 4.4% | 1.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | — |
8季度趋势，按日历期对齐
经营现金流PLXUK
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $-5.2M | — | ||
| Q1 25 | $-5.1M | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $-3.6M | $-677.0K | ||
| Q4 23 | $3.6M | — |
自由现金流PLXUK
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $-3.8M | $-892.0K | ||
| Q4 23 | $3.3M | — |
自由现金流率PLXUK
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -36.2% | — | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | -28.1% | -5.5% | ||
| Q4 23 | 31.9% | — |
资本支出强度PLXUK
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.3% | 1.3% | ||
| Q4 23 | 2.4% | — |
现金转化率PLXUK
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
UK
暂无分部数据
